The Global Market for Bone Graft Substitutes is Projected to Reach US$3.2 Billion by 2022

Increasing Volume of Orthopedic Surgeries to Drive Growth in the Global Bone Graft Substitutes Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Bone Graft Substitutes market. The global market for Bone Graft Substitutes is projected to reach US$3.2 billion by 2022, driven primarily by the growing number of orthopedic surgeries performed worldwide and the development of novel bone graft substitutes and materials.

Bones are biologically active tissues that offer protection to the body and organs, enable movement, and are production locations for blood cells. Damaged or diseased bones necessitate bone grafting procedures, wherein missing bones are replaced with bone sourced from another part of the patient or by using a natural or artificial bone substitute. An ideal bone graft substitute (BGS) is easy to use, structurally similar to bone, biocompatible, osteoconductive, osteoinductive and also cost effective. Bone grafts substitutes are used in various cases such as arthroplasty, trauma, and foot/hand procedures. The global bone graft substitutes market is driven by the increasing number of number of spinal fusion and joint reconstruction procedures performed globally, which warrant the use of bone graft. Sustained demand for orthopedic procedures from an aging global population and the expanding pool of younger patients will also present opportunities for growth. Rising awareness among surgeons and patients about the advantages of bone regeneration through biologics and the development of advanced bone grafts are also driving market growth. In the field of dentistry, the increasing prevalence of periodontal diseases and the rising incidence of dental fractures are driving demand for dental bone grafts.

In the coming years, the market will witness healthy growth driven by advancements in bone graft materials, and development of innovative products. The growing prevalence of obesity and the subsequent rise in conditions such as osteoarthritis and arthritis will enhance the need for bone grafting procedures. Further, the market is expected to benefit from the fast-paced technological changes that are driving shift from autografts to allografts, increasing penetration of synthetic bone grafts, and improving industry standards.

As stated by the new market research report on Bone Graft Substitutes, the United States represents the largest market, worldwide, supported by societal aging, rise in bone disorders, spurt in orthopedic procedures, and favorable reimbursement policies for orthopedic procedures. Asia-Pacific ranks as the fastest growing market with a CAGR of 11.6% over the analysis period, led by factors such as developing healthcare infrastructure, expanding base of affluent middle class population and a parallel increase in per capita healthcare spending, expansion in the scale of dental practice and the ensuing rise in demand for dental bone graft substitute; and the growing trend towards medical tourism and the resulting increase in surgical procedures and treatments.   

Major players covered in the report include AlloSource, Baxter International Inc., DePuy Synthes Companies, Exactech Inc., Integra LifeSciences Holdings Corporation, LifeNet Health Inc., Medtronic plc, NovaBone Products LLC, NuVasive Inc., Orthofix International N V, RTI Surgical Inc., Smith & Nephew Plc, Stryker Corporation, Wright Medical Group N.V., Zimmer Biomet Holdings Inc., among others.

The research report titled “Bone Graft Substitutes: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets such as the US, Japan, Europe (France, Germany, Italy, UK, Spain and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America) and Rest of World. The US market for Bone Graft Substitutes is analyzed by the following product segments - Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BMP), Stem Cell Based Bone Grafts, and Synthetic Bone Grafts.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.